Loading…

Influence of mHealth-Based Lifestyle Interventions on Symptoms of Anxiety and Depression of Women With Gestational Diabetes: A Meta-Analysis

Background: Symptoms of anxiety and depression are common in women with gestational diabetes mellitus (GDM). Mobile health (mHealth)-based lifestyle interventions have been shown to be effective in improving glycemic control of these women. Purpose/Objective: The aim of the study was to evaluate the...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nursing research 2024-07, Vol.33 (6), p.448-459
Main Authors: Liao, Rong, Li, Yamin, Yang, Hui, Luo, Yaoyue
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Symptoms of anxiety and depression are common in women with gestational diabetes mellitus (GDM). Mobile health (mHealth)-based lifestyle interventions have been shown to be effective in improving glycemic control of these women. Purpose/Objective: The aim of the study was to evaluate the influence of mHealth-based lifestyle interventions on symptoms of anxiety and depression in women with GDM. Design: A systematic review and meta-analysis or randomized controlled trials. Setting: Clinical or community-based settings. Sample: Nine studies involving 1,168 pregnant women with GDM were included. Intervention: mHealth-based lifestyle interventions. Measures: Symptoms of anxiety and depression quantitatively analyzed in clinical scales. Analysis: A systematic literature search was performed in electronic databases, including PubMed, Cochrane library, Embase, Web of Science, Wanfang, and China National Knowledge Infrastructure to obtain relevant randomized controlled studies. A random-effects model was used to pool the results by incorporating the impact of the potential heterogeneity. Results: Findings revealed that when compared to usual care, women who received mHealth-based lifestyle interventions had significant improvements in symptoms of anxiety (standardized mean difference [SMD]: −0.55, 95% CI [−0.77, −0.33], p 
ISSN:1054-7738
1552-3799
1552-3799
DOI:10.1177/10547738241252885